Search research articles
Contact Us
Filters
Showing results (661-670 of 678) with videos related to
Page
of 68
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
September 19, 2025
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group Database
Ke Su, Xiao-Rong Hou, Qiu-Zi Zhong, et al.
Leukemia
|
September 18, 2020
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Yong Yang, Ying Wang, Xin Liu, et al.
Ejhaem
|
February 23, 2023
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database
Xuan Zheng, Bao-Lin Qu, Xin Liu, et al.
American Journal of Hematology
|
May 26, 2020
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study
Shu-Nan Qi, Yong Yang, Yu-Jing Zhang, et al.
Therapeutic Advances in Medical Oncology
|
October 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma
Fei Luo, Qiu-Zi Zhong, Xin Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2022
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
Feng Wang, Ming-Ming He, Jian Xiao, et al.
Annals of Hematology
|
June 12, 2023
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
Jia-Ying Li, Xiao-Rong Hou, Si-Ye Chen, et al.
Leukemia
|
March 11, 2020
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making
Si-Ye Chen, Yong Yang, Shu-Nan Qi, et al.
Cost Effectiveness and Resource Allocation : C/E
|
August 18, 2021
Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey
Xin Zhang, Ju-Fang Shi, Guo-Xiang Liu, et al.
Nature Genetics
|
July 21, 2015
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
Lu Jiang, Zhao-Hui Gu, Zi-Xun Yan, et al.
Page
of 68
Search research articles
Search
Showing results (661-670 of 678) with videos related to
Sort By:
Page
of 68
International Journal of Radiation Oncology, Biology, Physics
|
September 19, 2025
Survival Benefit of Adjuvant Radiation Therapy Following Asparaginase-Based Chemotherapy in Patients With Chemoresponsive Advanced-Stage Extranodal NK/T Cell Lymphoma: A Multicenter Study Using the China Lymphoma Collaborative Group Database
Ke Su, Xiao-Rong Hou, Qiu-Zi Zhong, et al.
Leukemia
|
September 18, 2020
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study
Yong Yang, Ying Wang, Xin Liu, et al.
Ejhaem
|
February 23, 2023
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database
Xuan Zheng, Bao-Lin Qu, Xin Liu, et al.
American Journal of Hematology
|
May 26, 2020
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study
Shu-Nan Qi, Yong Yang, Yu-Jing Zhang, et al.
Therapeutic Advances in Medical Oncology
|
October 14, 2024
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma
Fei Luo, Qiu-Zi Zhong, Xin Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 5, 2022
A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
Feng Wang, Ming-Ming He, Jian Xiao, et al.
Annals of Hematology
|
June 12, 2023
Outcome and risk prediction of early progression in patients with extranodal natural killer/T cell lymphoma from the CLCG study
Jia-Ying Li, Xiao-Rong Hou, Si-Ye Chen, et al.
Leukemia
|
March 11, 2020
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making
Si-Ye Chen, Yong Yang, Shu-Nan Qi, et al.
Cost Effectiveness and Resource Allocation : C/E
|
August 18, 2021
Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey
Xin Zhang, Ju-Fang Shi, Guo-Xiang Liu, et al.
Nature Genetics
|
July 21, 2015
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
Lu Jiang, Zhao-Hui Gu, Zi-Xun Yan, et al.
Page
of 68